drugset / Trial / NCT00395629
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Brief Summary: This study was designed to explore a safe dose and characterize the preliminary safety and efficacy of ICL670 in adult patients with previously documented history of homozygous C282Y.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-12
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferasirox | Unknown | 5 mg/kg | — |
| Subject | Deferasirox | Unknown | 10 mg/kg | — |
| Subject | Deferasirox | Unknown | 15 mg/kg | — |